PUBLISHED FOR OPPOSITION
on 10 Dec 2024
Last Applicant/ Owned by
Salisbury House, Station Road
Cambridge
GB
13354764
Serial Number
98426932 filed on 29th Feb 2024
Registration Number
N/A
Correspondent Address
Scott D. Locke
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
EPITOPEA
Scientific research for medical purposes in the area of cancerous diseases; Research and development in the fields of oncology, and immunology; Research and development services in the fields of oncology and immunology research and development; Drug discovery; drug development; Medical and scientific research, namely, conducting clinical trials for others; Research relating to genetics; Research a Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific research for medical purposes in the area of cancerous diseases; Research and development in the fields of oncology, and immunology; Research and development services in the fields of oncology and immunology research and development; Drug discovery; drug development; Medical and scientific research, namely, conducting clinical trials for others; Research relating to genetics; Research and development in the field of therapeutics; Research and development in the fields of biotechnology, pharmaceuticals, diagnostic preparations, vaccines, medicines, molecular sciences, clinical trials and therapeutics; Scientific laboratory services; Laboratory testing and analysis of materials; Biological research laboratory services; Services of a chemical laboratory; Development of biochemical reagents; Research and development of biological drug delivery platforms; Development of computer software, computing methods and algorithms; Computer programming; Database design; Online database maintenance for others; Design and development of computer software for use with medical technology; Design and development of software for medical diagnostic or veterinary diagnostic purposes; Design and development of computer systems for data input, output, processing, display and storage; technical surveying; Analysis of technical data, namely, oncology and immunology data; Research relating to data processing; Provision of research information and data relating to medical and veterinary research and development; Scientific research in the field of oncology and immunology conducted using databases; Consultancy, information and advisory services relating to all of the aforesaid services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical, medical or veterinary preparations and substances for the treatment of cancer and diseases of the immune system; Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; Compounds for treating cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer and diseases of the immune system for use in the fields of medicine, health, oncology, immunology; biological compounds or preparations for the treatment of cancer and diseases of the immune system; biological compounds or preparations for the prevention of cancer and diseases of the immune system; Therapeutic preparations for cancer and diseases of the immune system; Genetic markers for therapeutic or diagnostic use; Cells for medical use; pharmaceutical preparations for the prevention or treatment of tumors; Pharmaceutical preparations for activating cellular function; Cell growth media for growing cells for medical use; Cellular function activating agents for medical purposes; Reconstituted cells for medical treatments; Preparations for detecting genetic predispositions for medical purposes; Pharmaceutical preparations for the prevention or treatment of immune system related diseases and disorders; Immunomodulators; Immunostimulants; Pharmaceutical preparations for immunity adjustment; Immunoassay reagents for medical use; Immunotherapeutic agents for use in treating bacterial infections; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Vaccines; Tumor antigens for medical use; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use; Biological compounds for use in the targeted pharmaceutical therapies; Proteins with diagnostic and therapeutic uses for medical use; Proteins for medical use; Diagnostic reagents for medical use; Reagents and substances for use in testing for medical purposes; Diagnostic and testing preparations for clinical, medical and medical laboratory use; Diagnostic and testing apparatus in the field of modulating therapeutics; Biomarkers for medical use; Nucleic acid sequences for medical purposes; Nucleic recombinant acids for medical use; Biological preparations and biological compounds for the treatment of cancer and diseases of the immune system; Biological reagents for medical use; Biological tissue cultures for medical purposes; Indicators for medical diagnosis; In vivo diagnostic scanning agents for medical use; Diagnostic agents for pharmaceutical or medical use; Diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of peptides, nucleic acids, buffers, and reagents, for medical purposes; Medical diagnostic test strips for use in the field of cancer and diseases of the immune system; Pharmaceutical preparations for the treatment of cancers
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Cells for scientific or research purposes; chemical substances for use in the manufacture of medicinal and pharmaceutical products; Chemicals, reagents and substances for medical research purposes; Immunoassay reagents, other than for medical or veterinary use; Chemicals for use in immuno-assay testing other than for medical or veterinary use; Immunoassays based on polypeptides for determining immunological profile, other than for medical or veterinary use; Diagnostic preparations and reagents for scientific or research use; Test kits consisting primarily of peptides, nucleic acids, buffers, and reagents for scientific or research use; Nucleic recombinant acids other than for medical or veterinary purposes; Nucleic acid sequencing programs, other than for medical or veterinary use; Chemical reagents for use in oncology research; Reagents for medical research; Diagnostic reagents, other than for medical or veterinary use; Cell culture reagents for scientific and research use; Biological preparations for use in cell cultures other than for medical or veterinary use; Substances for use in genetic probe assay kits, other than for medical or veterinary use; Antibodies for scientific purposes
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Compilation of statistical data relating to medical research for business purposes; Database management; Data processing; Data processing, systematization and management; Data processing services in the field of healthcare; Promoting public awareness of diseases, available medical treatments and disease prevention practices; Promoting public awareness of medical conditions, diagnosis of medical conditions and prevention of medical conditions; Consultancy and advisory services relating to all of the aforesaid services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98426932
Mark Type
No Service Mark
Attorney Docket Number
No Epitop 03-US
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Dec 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Dec 2024 | PUBLISHED FOR OPPOSITION |
| 04th Dec 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 12th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 07th Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 07th Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 07th Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 17th Sep 2024 | ASSIGNED TO EXAMINER |
| 17th Sep 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 17th Sep 2024 | NON-FINAL ACTION WRITTEN |